SWElife Personalized Medicine

Purpose and goal

Goal: To Facilitate the development of health care, to use and evaluate innovation as well as to work health care and individually-based. Therefore, funding from Swelife National Coordination efforts has been invested in carried out two concrete preliminary studies to accelerate this process of changes: * PRALIN Predictive biomarkers follow-up and monitoring in the National Cancer Guidelines * National standardization of tissue collection from cancer patients. Both projects have delivered according to plan and will now be pushed forward in other projects / initiatives

Expected results and effects

*PRALIN: 1. Evaluation shows that the cancer portal can be used to monitor biomarker status. 2. Analysis has created the conditions for connecting more cancer diagnoses where both, biomarkers and clinical data, are recorded *The tissue project: 1. Co-operation has contributed in the development of a new main agreement for the biobusiness area between universities and county councils in 2016-17, where industry partners will join as well. 2. The project has contributed to a comprehensive approach to biobank demand in Sweden following the end of BBMRI.se.

Planned approach and implementation

PRALIN: The project has shown that the infrastructure currently available through the national quality records can be extended with a molecular pathological module and used for follow-up of predictive biomarkers. The work is further pursued through another Swelif project. The tissue project: The study shows that the investments required to support tissue management are estimated to be less costly compared to the SIB program for blood biobanking. The work is continued through Biobank Sweden, the national biobanks infrastructure supported by the Swedish Research Council.